Document Detail


Risk assignment in childhood brain tumors: the emerging role of molecular and biologic classification.
MedLine Citation:
PMID:  11822983     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Brain tumors as a group are the most common solid tumors of childhood and currently have the highest mortality rate. A major emphasis has historically been placed on stratifying therapy for these tumors based on histologic and clinical prognostic factors. However, with the increasing application of molecular approaches to refine the categorization of these tumors, it has become apparent that histologically comparable lesions may exhibit diverse patterns of gene expression and genomic alterations, which may correspond with important prognostic distinctions. This paper summarizes these observations and discusses how they are being applied in a preliminary fashion as a foundation for risk-adapted stratification of childhood brain tumor therapy.
Authors:
Ian F Pollack; Jaclyn Biegel; Allan Yates; Ronald Hamilton; Sydney Finkelstein
Related Documents :
6249513 - Experimental and clinical effect of acnu in japan with emphasis on small-cell carcinoma...
10511083 - Brain tumor surgery in geriatric patients: a critical analysis in 44 patients over 80 y...
20303753 - A novel d-glucose derivative radiolabeled with technetium-99m: synthesis, biodistributi...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Current oncology reports     Volume:  4     ISSN:  1523-3790     ISO Abbreviation:  Curr Oncol Rep     Publication Date:  2002 Mar 
Date Detail:
Created Date:  2002-02-01     Completed Date:  2002-04-18     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  100888967     Medline TA:  Curr Oncol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  114-22     Citation Subset:  IM    
Affiliation:
Department of Neurosurgery, Children"s Hospital of Pittsburgh, Main Tower, Floor 3, Room 3705, 3705 Fifth Avenue, Pittsburgh, PA 15213, USA. pollaci@chplink@chp.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Brain Neoplasms* / classification*,  epidemiology,  genetics*
Child, Preschool
Gene Expression Regulation, Neoplastic
Genetic Markers*
Glioma / classification,  genetics
Humans
Medulloblastoma / classification,  genetics
Neuroectodermal Tumors, Primitive / classification,  genetics
Prognosis
Risk Factors
Time Factors
Tumor Markers, Biological*
Grant Support
ID/Acronym/Agency:
CA13539/CA/NCI NIH HHS; CA46274/CA/NCI NIH HHS; NS01810/NS/NINDS NIH HHS; NS37704/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
0/Genetic Markers; 0/Tumor Markers, Biological

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pediatric non-Hodgkin's lymphoma: clinical and biologic prognostic factors and risk allocation.
Next Document:  Risk assignment in pediatric soft-tissue sarcomas: an evolving molecular classification.